Walker's Research Business Information
A publisher of Business Information since 1983  
Search Business Search Executive   Advanced Search
Sign In  |  Hints

Profile of Antonio Iavarone

Antonio Iavarone

Member - Scientific Advisory Board - AngioGenex Inc.
Antonio Iavarone Email :
Please login
Company Name : AngioGenex Inc.
Company Website : www.angiogenex.com
Company Address : 425 Madison Ave. 902
, New York, NY,
United States,
Antonio Iavarone Profile :
Member - Scientific Advisory Board - AngioGenex Inc.
Antonio Iavarone Biography :

Dr. Iavarone, 40, is Professor at the Institute for Cancer Genetics, Columbia University. Dr. Iavarone received his medical degree in 1987 at the Catholic University of Rome, Italy. There, he found that cells derived from neuroblastoma, a highly malignant tumor of children, can specifically take up a new anti-cancer molecule, MIBG. In 1991, Dr. Iavarone joined the Brain Tumor Research Center of the University of California at San Francisco, where he showed that the ectopic expression of a member of the Id family, Id2, overrides a key tumor suppressor network that normally operates in all mammalian cells. Beginning in 1998, Dr. Iavarone continued his analysis of the role played by Id proteins in human cancer at the Albert Einstein College of Medicine, where he directed the neuro-oncology research program at the Albert Einstein Comprehensive Cancer Center. He recently discovered that Id2 accumulates in prognostically unfavorable neuroblastoma

Antonio Iavarone Colleagues :
Name Title Email

William Garland

COO Please login

George Gould

Gerneral Counsel Please login

Michael Strage

Chmn., Head - Business Devlopment Please login

Martin Murray

Dir., CFO, Sec., Treasurer Please login

Richard Salvador

Dir., CEO, Pres. Please login

            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   

2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.